May 10, 2022 / 05:00PM GMT
Alec Warren Stranahan - BofA Securities, Research Division - Associate
Hey, everyone, good morning. Welcome to day 1 of the 2022 BofA Healthcare Conference, and thanks for joining the session with MeiraGTx. My name is Alec Stranahan. I'm Vice President and Senior Biotech analyst covering Meira here at BofA, and I'm pleased to be joined by Zandy Forbes, who's the President and Chief Executive Officer of Meira. I believe Zandy is going to run through some slides to start, and then we'll get into the Q&A. So with that, Zandy, over to you.
Alexandria Forbes - MeiraGTx Holdings plc - CEO, President & Director
Thank you, and thank you for inviting me to speak to this exclusive group. I hope that what I show you today will impress you enough to run away and tell your friends how amazing Meira is. So we are a gene therapy company and very unusual because of the way we were set up. We started in 2015, not to focus on a particular indication, but rather on the capabilities that are required for any gene therapy company to have a clinical pipeline and commercialize
MeiraGTx Holdings PLC at Bank of America Healthcare Conference Transcript
May 10, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers